Intracardiac or intrapulmonary shunts were present in at least 35% of adults with homozygous sickle cell disease followed in an outpatient clinic
Bryan C. Hambley,
Rania Abdul Rahman,
Maxwell Reback,
Mary Ann O’Riordan,
Nathan Langer,
Robert C. Gilkeson,
Mahazarin Ginwalla,
Jane A. Little,
Robert Schilz
Affiliations
Bryan C. Hambley
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University Hospitals Cleveland Medical Center (UHCMC) and Case Western Reserve University (CWRU)
Rania Abdul Rahman
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University Hospitals Cleveland Medical Center (UHCMC) and Case Western Reserve University (CWRU)
Maxwell Reback
Division of Internal Medicine, Department of Medicine, UHCMC and CWRU
Mary Ann O’Riordan
Department of Pediatrics, Rainbow Baby and Children’s Hospital and CWRU
Nathan Langer
Division of Hematology and Oncology, Department of Medicine, UHCMC and CWRU
Robert C. Gilkeson
Division of Cardiothoracic Imaging, Department of Radiology, UHCMC and CWRU
Mahazarin Ginwalla
Division of Cardiovascular Medicine, Department of Medicine, UHCMC and CWRU, Cleveland, OH, USA
Jane A. Little
Division of Hematology and Oncology, Department of Medicine, UHCMC and CWRU
Robert Schilz
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University Hospitals Cleveland Medical Center (UHCMC) and Case Western Reserve University (CWRU)
